Introduction

World-Wide Webinar Series: Impact of Modeling & Simulation in Drug Development

This series aims to foster the use of Modeling and Simulation (M&S). Each session will demonstrate how M&S can support product discovery, development, or marketing programs. The series is intended for project team members, including pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinicians, regulatory affairs specialists, and Chief Medical and Scientific Officers.

Webinars are free, live sessions that include presentation and discussion sessions. Archived webinars; printable program (pdf)

 

Apr 16, 2015

12:00-1:00 EDT

 

May 13, 2015

12:00-1:00 EDT

 

Jun 17, 2015

12:00-1:00 EDT

 

  • TBD
  • Eric A. Sobie Ph.D., Associate Professor, Pharmacology and Systems Therapeutics 
    Sobie Laboratory - Icahn School of Medicine at Mount Sinai, NYC, NY

Jul 15, 2015

12:00-1:00 EDT

 

  • TBD
  • Stephen Duffull, PhD, Chair of Clinical Pharmacy, Otago Pharmacometrics Group, New Zealand

Aug 19, 2015

12:00-1:00 EDT

 

  • Summer break

Sept 16, 2015

12:00-1:00 EDT

 

  • TBD
  • Satyaprakash Nayak (Satya), Pharmacometrician - Systems Biologist at Pfizer

Nov 11, 2015

12:00-1:00 EST

 

  • TBD
  • Jonathan Wagg, MD, PhD, Disease Therapeutic Area Modeling Leader - Oncology, Roche Pharmaceutical Research and Early Development

Dec 9, 2015

12:00-1:00 EST

 

  • Modeler. Tailor. Listener. Buy
  • Peter L. Bonate, PhD, Senior Director, Astellas; Global Head - Pharmacokinetics, Modeling, and Simulation; Global Clinical Pharmacology & Exploratory Development

Jan 20, 2016

12:00-1:00 EST